233 F.R.D. 40 | D.C. Cir. | 2006
ORDER
Pending before the Court is Plaintiffs’ Renewed Motion for Class Certification [Doc. # 120]. Plaintiffs
I. Class Certification
Certification of a class requires the putative class representatives to prove (1) that the class is so numerous as to make joinder of all members impracticable, (2) that there are common questions of fact or law, (3) that the claims or defenses of the representative parties are typical of the claims or defenses of the class, and (4) that the representative parties will fairly and adequately protect the interests of the class. Fed.R.Civ.P. 23(a). If those urging class certification meet the first four prerequisites, they must then satisfy one of the subdivisions of Fed.R.Civ.P. 23(b). The subdivision relied on by the Plaintiffs for class certification is Rule 23(b)(3), which requires that the questions of fact or law common to the whole class predominate over any questions affecting only individual members, and that the class action is a superior method for adjudicating the controversy.
A. The Class Period
Defendants argue that any fraud inflating the market price of Iridium securities was disclosed on March 29, 1999, and after that date it was unreasonable for class members to rely on prior Iridium representations when they purchased Iridium securities. Among the March 29 disclosures cited by Defendants were the resignation of Iridium’s CFO, Defendant Roy Grant; a sixty day extension by Iridium’s lenders of its deadlines to achieve minimum subscriber and revenue covenants; and a notice to Iridium’s lenders that Iridium was revising its customer and revenue estimates and intended to seek a modification of the covenants once it finished its revisions. Also on that day came several reports about Iridium’s financial condition, including a Bloomberg News article noting a 27 percent drop in Iridium stock since February 18, 1999, following growing concern about the company’s ability to meet its covenants; a Reuter’s article reporting a 73 percent drop in Iridium’s stock price since its 52-week high the previous May; and a statement by stock analyst Tim O’Neill saying that he expected a drastic reduction in subscriber and revenue targets. As evidence of the market correction precipitated by these disclosures, Defendants point out that Iridium’s stock price dropped 30 percent from March 26 to March 31; that the Plaintiffs filed this lawsuit on April 22; and that in their original complaint, the Plaintiffs ended the class period on March 29 because that was the date on which, according to an early press release by Plaintiffs’ counsel, the Company’s fraudulent practices were disclosed.
Plaintiffs argue that they pushed back the close of the class period since filing their original April 1999 complaint because they now believe that the March 29 press release-on which they based the original closing date-was itself fraudulent.
When precisely any alleged fraud on the market was cured remains in dispute. The price of Iridium stock did fall following the March 29 press release which announced that the company was revising its customer and revenue estimates,
B. Sub-Class Certification with Aftermarket Purchasers
Defendant Underwriters urge the Court to reject the proposed Sub-Class because it includes not only those who bought shares in the Secondary Offering but also those whose aftermarket purchases are traceable to the Registration Statement. They correctly point out that aftermarket purchasers have no standing under Section 12 of the Securities Act of 1933 because Section 12 is limited to direct purchasers. DeMaria v. Andersen, 318 F.3d 170, 177-78 (2nd Cir.2003); Lee v. Ernst & Young, LLP, 294 F.3d 969, 976 (8th Cir.2002); Hertzberg v. Dignity Partners, Inc. 191 F.3d 1076, 1080-81 (9th Cir.1999). Because Mandelbaum bought his own shares during the Secondary Offering, there is no question as to his standing under Section 12. However, while he concedes that no aftermarket purchasers in the sub-class may recover under Section 12, Mandelbaum contends that the aftermarket purchasers may recover under Section 11.
Thus, the question for the Court to decide is whether the inability of aftermarket purchasers to recover under Section 12 defeats certification of a sub-class which pursues both Section 11 and 12 claims. The Court concludes that the answer is no because common questions of fact still predominate even though some members of the sub-class cannot recover under both Section 11 and 12.
If Mandelbaum’s claim is successful on the merits, those who bought directly during the Secondary Offering will be able to recover under both Section 11 and Section 12; those who can only trace their shares to the Registration Statement will only be able to recover under Section 11. The difference is essentially one of damages for the individual members of the sub-class. The common question of whether the registration statement contained any material misrepresentations predominates over the secondary issue of which class members can recover under both Sections 11 and 12 and which can only recover under Section 11. See, e.g., Schwartz v. Celestial Seasonings, Inc., 178 F.R.D. 545, 554 n. 4 (D.Colo.1998) (holding that the common question of whether the registration statement was misleading predominated over any secondary tracing issues as to whether plaintiffs could trace to one of the two offerings alleged in the complaint). Thus, the inclusion of aftermarket purchasers who lack standing under Section 12 does not automatically defeat certification of the sub-class.
Defendants, however, also contend that class certification is impractical because the tracing problem associated with aftermarket purchasers is insurmountable. This is because the aftermarket purchasers can recover under Section 11 only if they can actually trace their shares to the Registration Statement.
Iridium’s initial public offering of 12 million shares of Class A common stock came in
Several courts have found that tracing of aftermarket shares is often virtually impossible where there are other identical shares available on the market at the time of the Offering.
Mandelbaum concedes that those sub-class members who purchased their shares aftermarket may have difficulty tracing their stock to the Registration Statement. He argues, however, that potential difficulty proving damages by some of the sub-class members is an inappropriate basis for denying class certification. The Court agrees with Mandelbaum, and with other courts who have reached the same conclusion in similar circumstances. In Charal v. Pierce, Fed. Sec. L. Rep. P 98362, 1981 U.S. Dist. LEXIS 17497 (E.D.N.Y. Nov. 3, 1981), the U.S. District Court for the Eastern District of New York certified a class of shareholders who could trace their purchase of stock to a Registration Statement that was misleading under Section 11. Rejecting defendants’ argument that tracing the individual class members’ shares would be too difficult, that court held,
When, after establishment of liability, the time comes for each member of the class to prove his or her right to recover, it may be difficult, if not ... impossible for each person who did not purchase directly from LILCO itself to prove that he purchased securities issued under the 1978 prospectus and registration statement. Such potential difficulty down the line does not, however, warrant elimination at this stage of all those persons who purchased the 2,390,593 shares of LILCO stock from the underwriter defendants from the class since to do so would not result in protection of the claims of the class, but rather their summary elimination from the lawsuit without an opportunity to explore the factual and legal issues on which a resolution of the question may ultimately turn.
Id. at *22. See also, In re SeeBeyond Techs. Corp. Sec. Litig., 266 F.Supp.2d 1150, 1171-72 (C.D.Cal.2003) (“The Court acknowledges the defendants’ argument that it may be difficult or impossible to trace the stock pur
In the present case, any difficulty by individual class members in tracing their particular aftermarket-purchased shares to the Registration Statement is a secondary issue to be resolved after the predominant issue of Defendant Underwriters’ liability has been decided. It would be inappropriate to foreclose such Plaintiffs’ resort to the class action format simply because some of their cases may be difficult to prove. See Eisen v. Carlisle & Jacquelin, 417 U.S. 156, 177, 94 S.Ct. 2140, 40 L.Ed.2d 732 (1974) (“We find nothing in either the language or history of Rule 23 that gives a court any authority to conduct a preliminary inquiry into the merits of a suit in order to determine whether it may be maintained as a class action.”); Bynum v. District of Columbia, 214 F.R.D. 27, 40 (D.D.C.2003) (“[T]he Court will not make a preliminary inquiry into the merits in determining whether to certify the class.”).
II. Plaintiff Mandelbaum
Defendants object to Mandelbaum as a class and sub-class representative on the grounds that (A) his claims are not typical of the class or subclass because he cannot show loss causation, (B) common questions of law or fact do not predominate between his claims and the sub-class’s because he is subject to a unique loss causation defense, and (C) he does not adequately represent the class because, as an “in and out” purchaser, he has a conflict of interest with the rest of the class.
A. Mandelbaum’s Ability to Prove Loss Causation
Defendants argue that Mandelbaum is an inappropriate class representative because, unlike other putative class members, he did not own any Iridium securities on May 13, 1999. Mandelbaum bought 1,000 shares of Iridium stock on January 21, 1999, at the Secondary Offering price of $33.50 per share, and sold them on March 10 at $21 per share for a loss of $12,500. Since he sold his Iridium stock on March 10, believing the company was going to collapse even before the alleged fraud was fully revealed, Defendants argue that he cannot prove loss causation and, therefore, should not represent the class.
Defendants base their challenge on Dura Pharmaceuticals, Inc. v. Broudo, — U.S. -, 125 S.Ct. 1627, 161 L.Ed.2d 577 (2005), in which the Supreme Court dismissed a securities fraud claim because the plaintiff was unable to prove loss causation even though the plaintiff could prove an inflation of the stock price due to the defendants’ misrepresentations. Id. at 1629-31. Following the logic of Dura, Defendants argue that: “It is not enough for Mandelbaum to show that he purchased Iridium shares at a price inflated by the alleged misrepresentations.” Motorola’s Resp. to PL’s Renewed Mot. For Class Certification at 7. Therefore, Defendants claim that “[a]ny failure to show ‘loss causation’ is fatal to Mandelbaum’s claims.” Id.
Dura involved Section 10b of the Securities Exchange Act of 1934 and Rule 10b-5 fraud.
The larger class, of which Mandelbaum is one of six potential class representatives, does pursue a Rule 10b-5 fraud claim in Count IV of their Consolidated Amended Complaint. Mandelbaum contends, however, that he will be able to demonstrate loss causation in Count IV. Conceding that Dura held mere proof of price inflation due to misrepresentation insufficient to sustain a Rule 10b-5 claim, Mandelbaum argues that the Supreme Court stopped short of requiring plaintiffs to prove that they sold after a complete, corrective disclosure resulting in a large price decline. Indeed, reading Dura to require proof of a complete, corrective disclosure would allow wrongdoers to immunize themselves with a protracted series of partial disclosures. Several District Courts have, therefore, read Dura narrowly,
The question before the Court, then, is whether Mandelbaum will not be able to prove in his Rule 10b-5 claim that the decline in the price of his stock was proximately caused by Defendants alleged misrepresentations. As mentioned above, resolution of this issue would require the Court to venture into the merits of Mandelbaum’s claim and would be more appropriately considered in the context the Underwriters’ pending Motion for Summary Judgment.
Conceding that the absence of loss causation is an affirmative defense to Mandelbaum’s Section 11 and 12 claims against them, the Underwriter Defendants argue that his susceptibility to such a defense makes his ease atypical of the sub-class and renders him an inadequate representative. Their argument is not without support. In Kas v. Financial General Bankshares, Inc., the putative shareholder class representatives had voted against a merger for reasons unrelated to the alleged misrepresentations in the proxy statement that formed the basis of their fraud claim. 105 F.R.D. 453, 461-62 (D.D.C.1985). Unlike the majority of the class they sought to represent, they did not rely on the allegedly misleading proxy statement and were uniquely vulnerable to a lack of reliance defense. Id. The court held:
[Wjhere the representative parties are subject to unique defenses, their claim is not typical of the class. Where it is predictable that a major focus of the litigation will be on an arguable defense unique to the named plaintiff or a small subclass, then the named plaintiff is not a proper class representative. It is not necessary that the defense asserted against the putative class representative ultimately succeed. Rather, the presence of even an arguable defense peculiar to the named plaintiff or a small subset of the plaintiff class may destroy the required typicality of the class, as well as bring into question the named plaintiffs representation.
Id. at 462.
In the instant sub-class litigation, Mandelbaum may be susceptible to a lack of loss causation affirmative defense. In contrast to Kas, however, it is not unlikely that the Underwriter Defendants will raise the same affirmative defense against the sub-class as a whole. Because Mandelbaum sold his shares before the end of the class period and before the complete disclosure of Iridium’s commercial woes, it is possible that this affirmative defense may be easier to prove against him than it would be against those members of the sub-class who sold after the final disclosure. The Court cannot say, however, that the potential vulnerability to a lack of loss causation defense is unique to Mandelbaum’s case. The presence of the loss causation defense does not defeat the typicality of his claims
C. In and Out Purchasers
Defendants also challenge Mandelbaum on the grounds that his interests as a so-called “in and out” purchaser-one who buys and sells, before the end of the class period-conflict with the interests of class members who did not sell until after the class period ended. See In re Seagate Tech. II Sec. Litig., 843 F.Supp. 1341 (N.D.Cal.1994) (“Seagate II”). Under the Seagate II analysis, the “in and out” purchaser has an incentive to minimize the degree of stock inflation on the day he sold his shares-since the more it was inflated when he sold it, the less his own damages would be-while those class members who bought on the same day the “in and out” purchaser sold would want to maximize the stock inflation on that same day. Id. at 1347-50, 1359-62, 1364-67.
Seagate II has not been well received by other courts,
overstating] the importance of price inflation. The chief role of price inflation remains its function in determining each plaintiffs damages. The common questions with respect to whether misleading statements or omissions were made, whether such statements were material, and whether they were made with scienter, bind class members with more force than the varying questions related to price inflation drive them apart.
In re Gaming Lottery Sec. Litig., 58 F.Supp.2d 62, 70 (S.D.N.Y.1999). Even Sea-gate II itself noted that “This ‘seller-purchas
Having rejected each of the Defendants’ objections, the Court concludes that Mandelbaum is an appropriate class representative.
III. Conclusion
Accordingly, it is hereby
ORDERED that this action is certified under Rule 23(c)(1) of the Federal Rules of Civil Procedure, on behalf of a class consisting of all persons or entities who purchased Iridium securities, purchased Iridium call options, and/or sold Iridium put options during the period from September 8, 1998, to May 13, 1999, inclusive, (the “Class Period”) who suffered damages (the “Class”). A sub-class is certified under Rule 23(a)(4)(B) of the Federal Rules of Civil Procedure, consisting of all persons or entities who purchased Iridium Class A common stock pursuant to, or traceable to, a Registration Statement filed by Iridium on or about October 13,1998, amended November 13, 1998, who suffered damages (the “Sub-Class”). Excluded from the Class and Sub-Class are Defendants, the officers and directors of Iridium and Motorola, members of their immediate families and their legal representatives, heirs, successors and assigns, and any entity in which Defendants have or had a controlling interest. And it is
ORDERED that Plaintiffs Richard Ackerman, Richard Mandelbaum, Antonio Pianos, Robert Predaina, Remy’s Ltd., John Sekas, and Weda Developers, Inc., are hereby certified as class representatives on behalf of the Class. Plaintiff Richard Mandelbaum is also hereby certified as class representative on behalf of the Sub-Class. And it is
ORDERED that the law firms of Wolf Haldenstein Adler Freeman & Herz LLP and Milberg Weiss Bershad & Schulman LLP are designated as Plaintiffs’ Co-Lead Counsel for the Class, and Finkelstein Thompson & Loughran is appointed Plaintiffs’ Liaison Counsel for the Class. The law firms of Entwistle & Cappucei LLP and Beatie and Osborn LLP, along with Finkelstein Thompson & Loughran, are designated as Executive Committee Members. And it is
ORDERED that the parties shall present to the Court, within thirty days of the date of this Order, a proposed Order directing Class Notice and a form of Notice of the Pendency of this Action to the members of the Class and Sub-Class.
. Richard Ackerman, Richard Mandelbaum, Antonio Pianos, Robert Predaina, Remy’s Ltd., John Sekas, and Wade Developers, Inc., were appointed “lead plaintiffs'' by the Court's March 15, 2001, Order under Section 2ID of the Securities Exchange Act of 1934 and Section 27 of the Securities Act of 1933
. Plaintiffs maintain that Iridium knew on March 29 that they would not be able to satisfy its covenants even with the extension to May 31.
. Iridium’s stock closed at $19,938 (just before the disclosure) on March 29, and at $15,125 on March 31, a two day drop of 25 percent. Closing stock prices taken from http://bigcharts.marketwatch.com. The Court may take judicial notice of closing stock prices. See Fed.R.Evid. 201; SEC v. Bilzerian, 814 F.Supp. 116, 123 n. 19 (D.D.C. 1993); In re Delmarva Sec. Litig., 794 F.Supp. 1293, 1300 n. 5 (D.Del.1992); FMC Corp. v. Boesky, 727 F.Supp. 1182, 1196 n. 17 (N.D.Ill. 1989); Jacobsen Mfg. Co. v. Sterling Precision Corp., 282 F.Supp. 598, 602 (E.D.Wis.1968).
. It closed at $14.50 on May 13 and at $9,375 on May 17, a three day drop of 35 percent. Closing stock prices taken from http://bigcharts.marketwatch.com.
. Even if the common issues didn’t predominate, Plaintiffs could easily seek to certify two subclasses, one with Section 11 claims and one with Section 12 claims. Forcing the Plaintiffs to do so unnecessarily, however, would add yet another delay to what is already a long-lived case, especially since it would be much more efficient to consider these differences at the damages stage, if and when it is reached. This makes more sense than having repeated trials to decide the common questions of fact. Separate trials might also produce inconsistent findings.
. See, e.g., In re Initial Pub. Offering Sec. Litig., 227 F.R.D. 65, 118 (D.N.Y.2004); Abbey v. Computer Memories, Inc., 634 F.Supp. 870, 873 (N.D.Cal.1986); Klein v. Computer Devices, Inc., 591 F.Supp. 270, 273 n. 7 (S.D.N.Y.1984); Lorber v. Beebe, 407 F.Supp. 279, 287 (S.D.N.Y. 1975)
. See Williams v. Glickman, 1997 U.S. Dist. LEXIS 1683 (D.D.C.1997); See also Burley v. City of New York, 2005 U.S. Dist. LEXIS 4439 (S.D.N.Y. 2005); Adair v. Johnston, 221 F.R.D. 573 (M.D.Ala.2004); In re Copper Antitrust Litig., 196 F.R.D. 348 (W.D.Wis.2000).
. Plaintiffs in Rule 10b-5 cases must prove six elements: (1) a material misrepresentation, (2) scienter, (3) in connection with the purchase or sale of a security, (4) reliance, (5) economic loss, and (6) loss causation. See Dura, 125 S.Ct. at 1631.
. See e.g., In re GeoPharma, Inc. Sec. Litig, No. 04 Civ. 9463(SAS), 2005 WL 2431518, at *7 (S.D.N.Y. Sept.30, 2005) (holding that where an alleged misstatement conceals a condition or event which then occurs and causes plaintiff's loss, it is the materialization of the undisclosed condition or event which causes the loss, without need for a corrective disclosure); see also In re Parmalat Sec. Litig., No. 04 MD 1653(LAK), 2005 WL 1529035, 2005 U.S. Dist. LEXIS 12554 (S.D.N.Y. June 28, 2005) ("corrective disclosure” not necessary where subject of the misrepresentation and omissions caused loss); In re Loewen Group Inc. Sec. Litig., 395 F.Supp.2d 211, 218 (E.D.Pa.2005) (post-Dura decision, denying defendants' motion for partial summary judgment: "Plaintiffs have pleaded loss causation adequately by alleging that they purchased TLGI stock at an inflated price and lost money when the price fell.... Because the existence and significance of any losses is unclear, loss causation is an inappropriate ground for summary judgment.”); Stumpf v. Garvey, No. 02-MDL-1335-PB, 2005 WL 2127674, at *12, 2005 U.S. Dist. LEXIS 19154, at *42 (D.N.H. Sept. 2, 2005) (plaintiffs satisfied Dura "by alleging that defendants’ fraudulent misrepresentations and omissions caused the price of TyCom stock to be artificially inflated, so that when, over time, the true facts came out regarding TyCom’s prospects and the state of demand for bandwidth generally, facts that were at odds with defendants' prior representations, the stock lost value and investors suffered a loss.”) (internal citation omitted); In re OmniVision Techs., Inc., C-04-2297 SC, 2005 WL 1867717, at *5, 2005 U.S. Dist. LEXIS 16009, at *18-19 (N.D.Cal. July 29, 2005) (plaintiffs satisfied Dura by alleging: "Plaintiffs purchased OmniVision securities at artificially inflated prices and suffered damages when revelation of the true facts caused a decline in the value of their investments.”) (internal citation omitted)..
. See Eisen v. Carlisle & Jacquelin, 417 U.S. 156, 177, 94 S.Ct. 2140, 40 L.Ed.2d 732 (1974); Bynum v. District of Columbia, 214 F.R.D. 27, 40 (D.D.C.2003). See also, supra, note 9 and accompanying text.
. See, e.g., In re Baan Co. Sec. Litig., 2002 WL 32307825 at *7, 2002 U.S. Dist. LEXIS 27875 at *25 (D.D.C.2002) ("Seagate, however, is an outlier... and has been uniformly rejected by numerous other courts.”) (citations and footnote omitted); In re Oxford Health Plans, Inc. Sec. Litig., 191 F.R.D. 369, 377 (S.D.N.Y.2000) ("[T]he holding in Seagate has been widely discredited."); In re Lucent Techs. Inc. Sec. Litig., 194 F.R.D. 137, 153 n. 20 (D.N.J.2000) ("Most courts ... have rejected the analysis of the Retention/Seller Conflict set forth in Seagate II.").